C4 Therapeutics Ownership | Who Owns C4 Therapeutics?

Overview Forecast RevenueFinancials Chart

C4 Therapeutics Ownership Summary

C4 Therapeutics is owned by 88.45% institutional investors, 11.56% insiders. Lynx1 capital management lp is the largest institutional shareholder, holding 10.00% of CCCC shares. Wasatch Ultra Growth is the top mutual fund, with 3.70% of its assets in C4 Therapeutics shares.

CCCC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	C4 Therapeutics	88.45%	11.56%	-0.01%
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Lynx1 capital management lp	6.88M	10.00%	$31.79M
Ra capital management	4.88M	7.09%	$22.54M
Wasatch advisors lp	4.85M	7.04%	$22.39M
Blackrock	4.55M	6.61%	$21.03M
Soleus capital management	4.05M	5.89%	$18.72M
Vanguard group	3.56M	5.17%	$16.43M
Commodore capital lp	3.41M	4.96%	$15.76M
State street	2.99M	4.35%	$13.84M
Balyasny asset management	1.94M	2.81%	$8.94M
Bank of america corp /de/	1.77M	2.57%	$8.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lynx1 capital management lp	6.88M	2.06%	$31.79M
Soleus capital management	4.05M	1.65%	$18.72M
Silverarc capital management	1.44M	1.57%	$6.67M
Commodore capital lp	3.41M	1.08%	$15.76M
Tcg crossover management	1.28M	0.61%	$5.90M
Bain capital life sciences investors	1.11M	0.56%	$5.14M
Ra capital management	4.88M	0.30%	$22.54M
Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group	85.00K	0.15%	$392.70K
Atom investors lp	332.62K	0.15%	$1.54M
Orbimed advisors	1.51M	0.14%	$6.99M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	4.55M	0.00%	3.65M
Lynx1 capital management lp	6.88M	2.06%	3.25M
Soleus capital management	4.05M	1.65%	1.59M
Orbimed advisors	1.51M	0.14%	1.51M
Geode capital management	1.36M	0.00%	851.90K

Top Sellers

Holder	Shares	% Assets	Change
State street	2.99M	0.00%	-4.16M
Price t rowe associates inc /md/	62.31K	-	-2.05M
Citigroup	30.46K	0.00%	-740.27K
Rafferty asset management	185.74K	0.00%	-647.94K
Point72 asset management	278.58K	0.00%	-627.89K

New Positions

Holder	Shares	% Assets	Change	Value
Orbimed advisors	1.51M	0.14%	1.51M	$6.99M
Nuveen asset management	431.01K	0.00%	431.01K	$1.99M
Tang capital management	200.00K	0.09%	200.00K	$924.00K
Hennion & walsh asset management	142.83K	0.03%	142.83K	$659.88K
Alpine global management	57.53K	0.05%	57.53K	$265.78K

Sold Out

Holder	Change
Gradient investments	-25.00
Us bancorp \de\	-39.00
Federated hermes	-316.00
Entrypoint capital	-458.00
Piscataqua savings bank	-600.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	119	7.21%	60,865,031	4.84%	88	1.23%	66	-1.49%	34	25.93%
Mar 31, 2024	111	16.84%	58,053,690	23.80%	84	1.01%	67	21.82%	27	8.00%
Dec 31, 2023	95	15.85%	46,893,581	35.38%	91	1.85%	55	44.74%	25	-16.67%
Sep 30, 2023	82	-16.33%	34,638,219	1.31%	70	1.45%	38	-25.49%	30	-16.67%
Jun 30, 2023	98	-16.95%	34,189,689	-8.52%	69	1.20%	51	-19.05%	36	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Wasatch Ultra Growth	2.61M	3.70%	119.16K
Vanguard Total Stock Mkt Idx Inv	2.14M	3.03%	-
SPDR® S&P Biotech ETF	1.59M	2.25%	17.56K
iShares Russell 2000 ETF	1.53M	2.17%	-3.44K
Wasatch Micro Cap	1.24M	1.76%	674.64K
Biotech Growth Ord	1.17M	1.65%	476.80K
Vanguard Institutional Extnd Mkt Idx Tr	789.52K	1.12%	-230.25K
Fidelity Small Cap Index	601.11K	0.85%	-13.94K
iShares Russell 2000 Value ETF	555.59K	0.79%	-
ArrowMark Small Cap Gro	500.62K	0.72%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

CCCC Ownership FAQ

Who Owns C4 Therapeutics?

C4 Therapeutics shareholders are primarily institutional investors at 88.45%, followed by 11.56% insiders and -0.01% retail investors. The average institutional ownership in C4 Therapeutics's industry, Biotech Stocks , is 44.85%, which C4 Therapeutics exceeds.

Who owns the most shares of C4 Therapeutics?

C4 Therapeutics’s largest shareholders are Lynx1 capital management lp (6.88M shares, 10.00%), Ra capital management (4.88M shares, 7.09%), and Wasatch advisors lp (4.85M shares, 7.04%). Together, they hold 24.13% of C4 Therapeutics’s total shares outstanding.

Does Blackrock own C4 Therapeutics?

Yes, BlackRock owns 6.61% of C4 Therapeutics, totaling 4.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 21.03M$. In the last quarter, BlackRock increased its holdings by 3.65M shares, a 402.93% change.

Who is C4 Therapeutics’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is C4 Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.06% of its assets in 6.88M C4 Therapeutics shares, valued at 31.79M$.

Who is the top mutual fund holder of C4 Therapeutics shares?

Wasatch Ultra Growth is the top mutual fund holder of C4 Therapeutics shares, with 3.70% of its total shares outstanding invested in 2.61M C4 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools